Literature DB >> 21440865

Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiology.

Michael R Zile1, Philip B Adamson, Yong K Cho, Tom D Bennett, Robert C Bourge, Mark F Aaron, Juan M Aranda, William T Abraham, Lynne Warner Stevenson, Fred J Kueffer.   

Abstract

BACKGROUND: The purpose of this study was to determine which pressure-based hemodynamic factor was most closely associated with the transition from chronic compensated to acute decompensated heart failure. METHODS AND
RESULTS: Intracardiac pressures were retrospectively examined in 274 heart failure patients using an implantable hemodynamic monitor. The relationship between the development of a heart failure-related event (HFRE) and 3 pressure variables were analyzed: peak estimated pulmonary artery diastolic pressure (ePAD) at the time of an HFRE, change in ePAD from baseline to peak pressure, and the product of ePAD pressure and time (P×T) calculated as the area under the pressure-versus-time curve from baseline to peak pressure. Patients without an HFRE served as control subjects. Peak ePAD and change in ePAD were not closely associated with the development of an HFRE. In patients with an HFRE, P×T was 221 ± 130 mm Hg·days with only 4% of the P×T values <60 mm Hg·days. In contrast, in patients without an HFRE, the P×T was 5 ± 23 with only 4% of the P×T values >60 mm Hg·days.
CONCLUSIONS: The product of small increases in pressure that occur over an extended period of time (P×T) is the pressure-based hemodynamic factor most closely associated with the transition to acute decompensated heart failure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21440865     DOI: 10.1016/j.cardfail.2011.01.010

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  15 in total

Review 1.  Remote Monitoring in Heart Failure: the Current State.

Authors:  Rajeev C Mohan; J Thomas Heywood; Roy S Small
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

2.  Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity.

Authors:  A L Pop-Moldovan; N-M Trofenciuc; D A Dărăbanţiu; C Precup; H Branea; R Christodorescu; M Puşchiţă
Journal:  Cancer Gene Ther       Date:  2017-03-03       Impact factor: 5.987

Review 3.  Remote Patient Monitoring in Heart Failure: Factors for Clinical Efficacy.

Authors:  Ankit Bhatia; Thomas M Maddox
Journal:  Int J Heart Fail       Date:  2020-11-30

4.  Fluid status and outcome in patients with heart failure and preserved ejection fraction.

Authors:  Benedikt Koell; Caroline Zotter-Tufaro; Franz Duca; Andreas A Kammerlander; Stefan Aschauer; Daniel Dalos; Marlies Antlanger; Manfred Hecking; Marcus Säemann; Julia Mascherbauer; Diana Bonderman
Journal:  Int J Cardiol       Date:  2016-12-21       Impact factor: 4.164

5.  Estimation of Changes in Intracardiac Hemodynamics Using Wearable Seismocardiography and Machine Learning in Patients With Heart Failure: A Feasibility Study.

Authors:  Md Mobashir Hasan Shandhi; Joanna Fan; J Alex Heller; Mozziyar Etemadi; Liviu Klein; Omer T Inan
Journal:  IEEE Trans Biomed Eng       Date:  2022-07-20       Impact factor: 4.756

Review 6.  Does Hemodynamic-Guided Heart Failure Management Reduce Hospitalization? A Systematic Review.

Authors:  Abdul M Minhas; Saba Ahmed; Muhammad S Khan; Kaneez Fatima; Muhammad N Anwar; Jonathan Constantin
Journal:  Cureus       Date:  2017-04-13

7.  A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management.

Authors:  Jeffrey S Tran; Aaron M Wolfson; Daniel O'Brien; Omid Yousefian; David M Shavelle
Journal:  Cardiol Res Pract       Date:  2019-07-17       Impact factor: 1.866

Review 8.  Nitrates for acute heart failure syndromes.

Authors:  Abel Wakai; Aileen McCabe; Rachel Kidney; Steven C Brooks; Rawle A Seupaul; Deborah B Diercks; Nigel Salter; Gregory J Fermann; Caroline Pospisil
Journal:  Cochrane Database Syst Rev       Date:  2013-08-06

9.  NephroCheck data compared to serum creatinine in various clinical settings.

Authors:  Sahra Pajenda; Aysegül Ilhan-Mutlu; Matthias Preusser; Sebastian Roka; Wilfred Druml; Ludwig Wagner
Journal:  BMC Nephrol       Date:  2015-12-09       Impact factor: 2.388

10.  Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.

Authors:  David M Shavelle; Akshay S Desai; William T Abraham; Robert C Bourge; Nirav Raval; Lisa D Rathman; J Thomas Heywood; Rita A Jermyn; Jamie Pelzel; Orvar T Jonsson; Maria Rosa Costanzo; John D Henderson; Marie-Elena Brett; Philip B Adamson; Lynne W Stevenson
Journal:  Circ Heart Fail       Date:  2020-08-06       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.